-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D3klqEHvv82D9t/nrd94bJcxDlwEHB+72v3avt5lNj1OQX8HfFAvoIOZjv37u3EK O9QFdzH26ZxVq5ssy9IqCQ== 0001209191-07-026520.txt : 20070501 0001209191-07-026520.hdr.sgml : 20070501 20070501140225 ACCESSION NUMBER: 0001209191-07-026520 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070427 FILED AS OF DATE: 20070501 DATE AS OF CHANGE: 20070501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHENK THOMAS E CENTRAL INDEX KEY: 0001204362 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 07805054 BUSINESS ADDRESS: STREET 1: MERCK & CO INC STREET 2: ONE MERCK DRIVE P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084231000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084231688 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2007-04-27 0 0000064978 MERCK & CO INC (MRK) 0001204362 SHENK THOMAS E PRINCETON UNIVERSITY, MOLECULAR BIOLOGY WASHINGTON ROAD PRINCETON NJ 08544-1014 1 0 0 0 Common Stock 1000 D Director Stock Option 2007/04/27 (right to buy) 51.86 2007-04-27 4 A 0 5000 0.00 A 2008-04-27 2017-04-26 Common Stock 5000 5000 D Phantom Stock 2007-04-27 4 A 0 1060.5476 51.86 A Common Stock 1060.5476 5507.6276 D The option vests in three equal annual installments beginning on April 27, 2008. 1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. Debra A. Bollwage as Attorney-in-Fact for Thomas E. Shenk 2007-05-01 -----END PRIVACY-ENHANCED MESSAGE-----